EMC Capital Management’s BioLife Solutions BLFS Stock Holding History

EMC Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-21,878	Closed	-$1.16M	–	119
2021 Q3	$1.16M	Hold	21,878	–	–	0.65%	43
2021 Q2	$974K	Sell	21,878 -3,624	-14%	-$128K	0.55%	54
2021 Q1	$918K	Sell	25,502 -6,673	-21%	-$264K	0.65%	51
2020 Q4	$1.28M	Buy	+32,175	New	+$1.1M	0.98%	29

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

EMC Capital Management's BLFS Position: Q4 2021 in Review

EMC Capital Management sold out of BioLife Solutions (BLFS) in Q4 2021, closing a stake of 21,878 shares — an estimated $1.16M sold.

EMC Capital Management first reported a position in BLFS in Q4 2020 and held it in 4 quarters. The position peaked at $1.28M in Q4 2020. 169 funds tracked by Wall St. Rank hold BLFS as of Q4 2021.

EMC Capital Management reported no remaining BioLife Solutions position as of Q4 2021 after selling out during the quarter.
EMC Capital Management sold 21,878 BioLife Solutions shares in Q4 2021, an estimated $1.16M.
EMC Capital Management first reported a position in BioLife Solutions in Q4 2020 and held it in 4 quarters.
EMC Capital Management's BioLife Solutions position peaked at $1.28M in Q4 2020.
169 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2021.

Based on EMC Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.